Journals / İnfeksiyon Dergisi / 2005 / Cilt: 19 - Sayı: 2

Recombinant DNA technology

Rekombiant DNA teknolojisi

Pages
263–270
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Large quantities of highly purified protein can be produced for clinical use thorough this technology.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Recombinant DNA technology refers to the transfer of a gene from one organism into another organism.
📊
Key Findings & Data:These molecules can then be introduced into bacteria, yeasts or other cells where they can replicate and function.
💡
Conclusion & Impact:Large quantities of highly purified protein can be produced for clinical use thorough this technology.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Recombinant DNA technology refers to the transfer of a gene from one organism into another organism. These molecules can then be introduced into bacteria, yeasts or other cells where they can replicate and function. Large quantities of highly purified protein can be produced for clinical use thorough this technology.

Özet

Rekombinant DNA teknolojisi, bir genin bir organizmadan diğerine transferidir. Oluşan rekombinant DNA molekülü bakteri, mantar veya diğer hücrelere aktarılarak replike olur ve fonksiyon gösterir. Bu teknoloji ile klinik kullanım için bol miktarda ve saf protein elde edilebilir.

🔖

Cite This Article

İMİR, T., FİDAN, I. (2022). Recombinant DNA technology. İnfeksiyon Dergisi, Cilt: 19 - Sayı: 2, 263–270. https://ajindex.com/articles/546494

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. 457 Lab Manual 2003. (http://www.umanitoba.ca/science/microbiology/staff/cameron/pdffiles/457m.04.pdf),[Erişim tarihi: 02.02.2004]. 2. Recombinant DNA technology Chapter 8A. http://biology.kenyon.edu/courses/biol114/Chap08/Chapter_08a.html, [Erişim tarihi: 14.10.2003]. 3. Recombinant DNA and gene cloning, http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/R/RecombinantDNA.html [Erişim tarihi: 05.11.2003]. 4. Solak M. Rekombinant DNA teknolojisinde uygulanan temel yöntemler. Solak M, Bağcı H, Şengil AZ, Öztaş S, ed. Moleküler Genetik ve Rekombinant DNA Teknolojisi. Ankara: Uyum Ajans, 2000: 83-170. 5. Recombinant DNA technology (http://www.bio.miami.edu/dana/250/25002_10.html) [Erişim tarihi: 05.02.2004]. 6. Ustaçelebi Ş. Viral genlerin klonlanması ve viral vektörler. XXVII. Türk Mikrobiyoloji Kongresi (4-10 Ekim 1998, Belek-Antalya) kitabında. İstanbul: Türk Mikrobiyoloji Cemiyeti, 1998: 31-2. 7. Man C, Byrne BJ, Flotte TR. Virus-based gene delivery systems. Clin Pharmacokinet 2002
  2. Romano G, Michell P, Pacilio C, Giordano A Latest developments in gene transfer technology: Achievements, perspectives, and controversies over therapeutic applications. Stem Cells 2000
  3. McGregor A, Schleiss MR. Recent advances in Herpesvirus genetics using bacterial artificial chromosomes. Mol Gen Metabolism 2001
  4. Kochi SK, Kileen KP, Ryan US. Advances in the development of bacterial vector technology. Expert Rev. Vaccines 2003
  5. Jonasson P, Liljeqvist S, Nygren PA, Stahl S. Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli. Biotech Appl Biochem 2002
  6. Applications of recombinant DNA technology, (http:www.immuneweb.com) [Erişim tarihi: 22.11.2003]. 13. Recombinant DNA technology (http://www.bi.umist.ac.uk/users/mjfssps/2GEN/default.asp.) [Erişim tarihi: 11.12.2003]. 14. Walsh G. Pharmaceutical biotechnology products approved within the European Union. Eur J Pharma Biopharma 2003
  7. Recombinant DNA technology and its applications. (http:/Aechno-preneur.net/timeis/technology/SciTechJan03/DNA.html) [Erişim tarihi:07.10.2003]. 16. Güzel Aİ, Kasap H. Gen tedavisi. Arşiv2001
  8. Atabey N. insan genom projesi tamamlanınca ne olacak: Fonksiyonel genomiks ve proteomiks. DEÜ Tıp Fakültesi Dergisi2002
  9. Özel Sayı: 121-31. 18. Hansson M, Nygren PA, Stahl S. Design and production of recombinant subunit vaccines. Biotechnol Appl Biochem 2000: